Anhydrous Citric Acid, Dextrose Monohydrate, And Trisodium Citrate Dihydrate

Generic Name: anhydrous citric acid, dextrose monohydrate, and trisodium citrate dihydrate

Calculi Dissolution Agent [EPC]Over-the-Counter (OTC)

Brand Names:

Anticoagulant Citrate Dextrose A

Description Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A), is a sterile, non-pyrogenic solution of citric acid, sodium citrate, and dextrose, in water for injection. Each 10 mL of solution contains: Citric Acid, anhydrous, USP 0.073 g Sodium Citrate, dihydrate, USP 0.220 g Dextrose, monohydrate, USP 0.245 g Water for Injection, USP q.s. pH: 4.5 – 5.5 Single patient use only, on a single occasion. single use

Overview

Description Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A), is a sterile, non-pyrogenic solution of citric acid, sodium citrate, and dextrose, in water for injection. Each 10 mL of solution contains: Citric Acid, anhydrous, USP 0.073 g Sodium Citrate, dihydrate, USP 0.220 g Dextrose, monohydrate, USP 0.245 g Water for Injection, USP q.s. pH: 4.5 – 5.5 Single patient use only, on a single occasion. single use

Uses

Indications and Usage Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Dosage

Dosage and Administration Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Side Effects

Adverse Reactions Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).

Warnings

Warnings NOT FOR DIRECT INTRAVENOUS INFUSION Contraindications NOT FOR DIRECT INTRAVENOUS INFUSION

Pregnancy

Pregnancy Long-term studies in animals have not been performed to evaluate the effects of ACD- A on pregnant women.

Storage

It is recommended that the product be stored at ambient room temperature, 24 °C (75 °F); however, the product can be stored between 15 °C (59 °F) and 30 °C (86 °F). Protect from freezing and exposure to excessive heat should be minimized.

Frequently Asked Questions

What is Anhydrous Citric Acid, Dextrose Monohydrate, And Trisodium Citrate Dihydrate used for?

Indications and Usage Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

What are the side effects of Anhydrous Citric Acid, Dextrose Monohydrate, And Trisodium Citrate Dihydrate?

Adverse Reactions Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).

Can I take Anhydrous Citric Acid, Dextrose Monohydrate, And Trisodium Citrate Dihydrate during pregnancy?

Pregnancy Long-term studies in animals have not been performed to evaluate the effects of ACD- A on pregnant women.

What are the important warnings for Anhydrous Citric Acid, Dextrose Monohydrate, And Trisodium Citrate Dihydrate?

Warnings NOT FOR DIRECT INTRAVENOUS INFUSION Contraindications NOT FOR DIRECT INTRAVENOUS INFUSION

Related Medications

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.